Obinutuzumab\uff08GA101\uff09\u306f\u9ad8\u3044\u594f\u52b9\u7387\u3092\u793a\u3059<\/p>\n
\u7b2c53\u56de\u7c73\u56fd\u8840\u6db2\u5b66\u4f1a\u300cASH2011\u300d\u306e\u901f\u5831\u3067\u3059\u3002 \u6ca2\u5c71\u306e\u6ffe\u80de\u6027\u30ea\u30f3\u30d1\u816b\uff08FL\uff09\u95a2\u9023\u306e\u767a\u8868\u304c\u306a\u3055\u308c\u305f\u3088\u3046\u3067\u3059\u3002 \u30ea\u30c4\u30ad\u30b5\u30f3\u304c\u52b9\u304b\u7121\u3044\u3082\u3057\u304f\u306f\u52b9\u304b\u306a\u304f\u306a\u3063\u305f\u65b9\u3078\u306e\u6717\u5831\u3067\u3059\u3002
\nhttp:\/\/medical.nikkeibp.co.jp\/inc\/all\/gakkai\/sp\/ash2011\/<\/p>\n
\u25c6\u4f4e\u60aa\u6027\u5ea6\u518d\u767a\u975e\u30db\u30b8\u30ad\u30f3\u30ea\u30f3\u30d1\u816b\u306bObinutuzumab\uff08GA101\uff09\u306f
\n\u3000\u3000\u30ea\u30c4\u30ad\u30b7\u30de\u30d6\u3088\u308a\u9ad8\u3044\u594f\u52b9\u7387\u3092\u793a\u3059<\/p>\n
http:\/\/cmad.nikkeibp.co.jp\/?4_136482_32272_4<\/p>\n
\u25c6\u4f4e\u60aa\u6027\u5ea6\u518d\u767a\u975e\u30db\u30b8\u30ad\u30f3\u30ea\u30f3\u30d1\u816b\u306bObinutuzumab\uff08GA101\uff09\u306f
\n\u3000\u3000\u30ea\u30c4\u30ad\u30b7\u30de\u30d6\u3088\u308a\u9ad8\u3044\u594f\u52b9\u7387\u3092\u793a\u3059<\/p>\n
\u3000\u4f4e\u60aa\u6027\u5ea6\u518d\u767a\u975e\u30db\u30b8\u30ad\u30f3\u30ea\u30f3\u30d1\u816b\uff08NHL\uff09\u306b\u5bfe\u3057\u3001\u5b8c\u5168\u30d2\u30c8\u5316\u6297CD20\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb
\n\u6297\u4f53\u88fd\u5264Obinutuzumab\uff08GA101\uff09\u306f\u30ea\u30c4\u30ad\u30b7\u30de\u30d6\u3088\u308a\u3082\u594f\u52b9\u7387\u304c\u9ad8\u304f\u3001\u6ce8\u5c04\u95a2\u9023\u53cd\u5fdc
\n\u3068\u54b3\u3092\u9664\u3051\u3070\u30ea\u30c4\u30ad\u30b7\u30de\u30d6\u3068GA101\u3067\u5fcd\u5bb9\u6027\u306b\u9055\u3044\u306f\u306a\u3044\u3053\u3068\u304c\u3001\u7121\u4f5c\u70ba\u5316\u30d5\u30a7\u30fc\u30ba2
\n\u8a66\u9a13\uff08GAUSS\uff09\u306e\u4e88\u5099\u89e3\u6790\u3067\u660e\u3089\u304b\u306b\u306a\u3063\u305f\u3002
\nhttp:\/\/cmad.nikkeibp.co.jp\/?4_136482_32272_7<\/p>\n
\n\u25c6\u518d\u767a\u30fb\u96e3\u6cbb\u6027\u4f4e\u60aa\u6027\u5ea6\u975e\u30db\u30b8\u30ad\u30f3\u30ea\u30f3\u30d1\u816b\u306bObinutuzumab\uff08GA101\uff09\u5358\u5264\u306f\u9ad8\u3044\u52b9\u679c<\/p>\n
\u3000\u518d\u767a\u30fb\u96e3\u6cbb\u6027\u4f4e\u60aa\u6027\u5ea6\uff08indolent\uff09\u975e\u30db\u30b8\u30ad\u30f3\u30ea\u30f3\u30d1\u816b\uff08NHL\uff09\u306b\u3001\u5b8c\u5168\u30d2\u30c8\u5316
\n\u6297CD20\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53\u88fd\u5264Obinutuzumab\uff08GA101\uff09\u5358\u5264\u306f\u9ad8\u3044\u52b9\u679c\u304c\u3042\u308b\u3053\u3068\u304c
\n\u30d5\u30a7\u30fc\u30ba1\/2\u8a66\u9a13\uff08GAUGUIN\u3001BO20999\uff09\u3067\u660e\u3089\u304b\u306b\u306a\u3063\u305f\u3002
\nhttp:\/\/cmad.nikkeibp.co.jp\/?4_136482_32272_10<\/p>\n
\u25c6\u6ffe\u80de\u6027\u30ea\u30f3\u30d1\u816b\u306bGA101\u3068\u5316\u5b66\u7642\u6cd5\u306e\u4f75\u7528\u306f\u5b89\u5168\u306b\u6295\u4e0e\u3067\u304d\u6297\u816b\u760d\u52b9\u679c\u304c\u9ad8\u3044<\/p>\n
\u3000\u518d\u767a\u30fb\u96e3\u6cbb\u6027\u6ffe\u80de\u6027\u30ea\u30f3\u30d1\u816b\u306b\u5bfe\u3057\u3001\u5b8c\u5168\u30d2\u30c8\u5316\u6297CD20\u30e2\u30ce\u30af\u30ed\u30fc\u30ca\u30eb\u6297\u4f53\u88fd\u5264
\nObinutuzumab\uff08GA101\uff09\u306fFC\u7642\u6cd5\uff08\u30d5\u30eb\u30c0\u30e9\u30d3\u30f3\u3001\u30b7\u30af\u30ed\u30db\u30b9\u30d5\u30a1\u30df\u30c9\uff09\u3084CHOP\u7642\u6cd5
\n\uff08\u30b7\u30af\u30ed\u30db\u30b9\u30d5\u30a1\u30df\u30c9\u3001\u30c9\u30ad\u30bd\u30eb\u30d3\u30b7\u30f3\u3001\u30d3\u30f3\u30af\u30ea\u30b9\u30c1\u30f3\u3001\u30d7\u30ec\u30c9\u30cb\u30be\u30ed\u30f3\uff09\u3068\u306e
\n\u4f75\u7528\u3067\u5b89\u5168\u306b\u6295\u4e0e\u3067\u304d\u3001\u594f\u52b9\u7387\u3082\u9ad8\u3044\u3053\u3068\u304c\u3001\u30d5\u30a7\u30fc\u30ba1b\u8a66\u9a13\uff08GAUDI\u3001BO21000\uff09
\n\u306e\u6700\u7d42\u7d50\u679c\u3067\u660e\u3089\u304b\u306b\u306a\u3063\u305f\u3002
\nhttp:\/\/cmad.nikkeibp.co.jp\/?4_136482_32272_11<\/p>\n
<\/p>\n","protected":false},"excerpt":{"rendered":"
\u7b2c53\u56de\u7c73\u56fd\u8840\u6db2\u5b66\u4f1a\u300cASH2011\u300d\u306e\u901f\u5831\u3067\u3059\u3002 \u6ca2\u5c71\u306e\u6ffe\u80de\u6027\u30ea\u30f3\u30d1\u816b\uff08FL\uff09\u95a2\u9023\u306e\u767a\u8868\u304c\u306a\u3055\u308c\u305f\u3088\u3046\u3067\u3059\u3002 \u30ea\u30c4\u30ad\u30b5\u30f3\u304c\u52b9\u304b\u7121\u3044\u3082\u3057\u304f\u306f\u52b9\u304b\u306a\u304f\u306a\u3063\u305f\u65b9\u3078\u306e\u6717\u5831\u3067\u3059\u3002<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-272","post","type-post","status-publish","format-standard","hentry","category-4"],"_links":{"self":[{"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=\/wp\/v2\/posts\/272","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=272"}],"version-history":[{"count":0,"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=\/wp\/v2\/posts\/272\/revisions"}],"wp:attachment":[{"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=272"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=272"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haruko.km2m.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=272"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}